Locations:
Search IconSearch
June 13, 2019/Neurosciences

Risk of Depression Is Twice as High in Patients With Nonallergic Rhinitis, Study Finds

Physicians caring for patients with rhinitis should be cognizant of association with depression

19-ENT-922-depressionRhinitis-CQD-650×450

In patients with nonallergic rhinitis, the risk of developing depression increased twofold compared to those without rhinitis, according to a recent study published in The Journal of Allergy and Clinical Immunology: In Practice. Without distinguishing between allergic and nonallergic rhinitis, rhinitis increased an individual’s odds of developing depression by 42%.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

A profound impact on quality of life

More than 17 million adults in the United States experienced at least one depressive episode in 2017, marked by a depressed mood and or loss of interest or pleasure in daily activities, and often leading to issues with sleep, eating, energy, concentration or self-worth.

There are approximately 60 million people in the United States living with allergic rhinitis, and 20 million people living with nonallergic rhinitis. Rhinitis can have a profound impact on the quality of life and productivity of patients. In patients also experiencing the impairments associated with depression, the impact on patients’ quality of life and relationships can be severe.

“There has been increasing evidence suggesting an association between depression and allergic and nonallergic disorders, but there was a dearth of evidence,” says Raj Sindwani, MD, Vice Chair for Cleveland Clinic’s Head and Neck Institute and Section Head of Rhinology. “To our knowledge, this is the first study assessing the association between allergic rhinitis, nonallergic rhinitis and depression in the U.S. population. We found that rhinitis is indeed significantly associated with depression in U.S. adults, but unexpectedly, patients with nonallergic rhinitis may be at a higher risk of depression than those with allergic rhinitis. We were quite surprised to uncover this relationship.”

Cleveland Clinic researchers analyzed data from a broad sample (n = 4,320) of people participating in the 2005-2006 National Health and Nutrition Examination Survey. For purposes of this study, rhinitis included self-reported symptoms of hay fever and/or nasal symptoms in the last 12 months. Rhinitis was classified as allergic rhinitis if participants objectively had a positive serum IgE, a unique strength of this large, population based study. Participants reporting rhinitis symptoms without a positive serum IgE to an aeroallergen were considered to have nonallergic rhinitis. Individuals were considered to have depression when they scored 10 or more on the Patient Health Questionnaire-9 (PHQ-9).

Advertisement

A closer look at comorbidities in patients with rhinitis

Subjects with rhinitis (n = 1,447) were more likely to be female (54.8% vs. 49.7%) and of poorer health than those without rhinitis (n = 2,873). Specifically, those with rhinitis were more likely to have asthma (21.8% vs 9.5%), chronic bronchitis (9.9% vs. 4.8%) and emphysema (3.2% vs 0.9%), as well as a depression score of more than 10 (7.0% vs 4.6%). In terms of severity of depression, subjects with rhinitis were 42% more likely to have depression scores ≥10 than those without rhinitis.

When the data were stratified by rhinitis type, those with nonallergic rhinitis (n = 692) were more likely to be female (61.7% vs 48.2%) and less likely to have asthma (15.4% vs 29.1%) than those with allergic rhinitis. Participants with nonallergic rhinitis were twice as likely to have depression compared to those with allergic rhinitis (n = 699), as indicated by a depression screener score of ≥10. Additionally, patients with nonallergic rhinitis were 64% more likely to have mild depression and were 2.4 times more likely to have moderate depression. The association between nonallergic rhinitis and depression was significant even when controlling for potentially confounding comorbidities.

“There are several potential factors that contribute to the increased risk of developing depression among patients with nonallergic rhinitis compared to those with allergic rhinitis,” explains Christopher Roxbury, MD, a rhinologist with Cleveland Clinic’s Head & Neck Institute. “These patients suffer from symptoms like nasal obstruction and rhinorrhea all year long, and their symptoms may be less responsive to treatment. While future studies might look at the relationship between duration or severity of symptoms and depression in patients with nonallergic rhinitis, physicians should consider depression in patients with longstanding nasal symptoms.”

Advertisement

Related Articles

gloved hand holding blood vial with neuropathology slide in background
October 10, 2025/Neurosciences/Epilepsy
Blood-Based Epigenetic Biomarkers Differentiate Focal Cortical Dysplasia Subtypes

Paired blood and brain tissue methylation findings raise prospect of noninvasive precision diagnosis

young man using walking canes on a city street
Vidofludimus for Progressive MS: No Impact on Brain Atrophy but Hints of a Role for Disability

Mixed results from phase 2 CALLIPER trial of novel dual-action compound

illustration of myelin sheaths wrapped around neuron axons
Revised McDonald Criteria for Multiple Sclerosis: A Big Step Toward Biomarker-Driven Diagnosis

A co-author of the new recommendations shares the updates you need to know

Dr. Jason Savage against a decorative background with podcast button overlay
October 2, 2025/Neurosciences/Podcast
Essentials of Revision Spine Deformity Surgery (Podcast)

Success for these complex operations requires judicious patient selection and presurgical patient optimization

physician talking with a patient in medical office
De-Escalation of Disease-Modifying Therapies in MS: A Real-World Look at Outcomes

Rebound risk is shaped by patient characteristics and mechanism of action of current DMT

woman speaking to a doctor
Tool Shows Promise for Individualized Decision Support on Stopping Disease-Modifying Therapy for Multiple Sclerosis

First-of-kind prediction model demonstrates high consistency across internal and external validation

health worker preparing infusion of injectable drug
Ocrelizumab Associated With Nearly Twofold Increase in Serious Infections Vs. Platform Injectables in Multiple Sclerosis

Real-world study also finds no significant rise in ocrelizumab-related risk with advanced age

two brain MRIs side by side with red circles on them
Cognitive Impairment in Multiple Sclerosis Linked to Rapid Thalamic Atrophy

Machine learning study associates discrete neuropsychological testing profiles with neurodegeneration

Ad